Complete Filing Data
Nuvation Bio Inc. reported Stockholders Equity of $305.72 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Nuvation Bio Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$204.6M | -$567.9M | -$75.8M | -$104.2M | -$86.8M | -$41.7M |
| Operating Income Loss | -$213.1M | -$592.6M | -$99.8M | -$119.7M | -$93.3M | -$43.6M |
| Other Comprehensive Income Loss Net Of Tax | $741.0K | -$145.0K | $5.7M | -$4.3M | -$2.7M | $1.1M |
| Research And Development Expense | $115.1M | $99.1M | $71.3M | $87.8M | $69.0M | $32.6M |
| Nonoperating Income Expense | $8.4M | $24.7M | $24.0M | $15.5M | $6.5M | $1.9M |
| Comprehensive Income Net Of Tax | -$205.4M | -$567.5M | -$70.1M | -$108.5M | -$89.6M | -$40.5M |
| Operating Expenses | $276.0M | $600.5M | $99.8M | $119.7M | $93.3M | $43.6M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$204.6M | -$567.9M | -$75.8M | -$104.2M | -$86.8M | -$41.7M |
| General And Administrative Expense | $28.5M | $31.9M | $24.3M | $10.9M | ||
| Selling General And Administrative Expense | $151.6M | $69.2M | $28.5M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $62.9M | $7.9M | $0.00 | |||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $5.0K | -$12.0K | -$139.0K | |||
| Gross Profit | $795.0K | $0.00 | ||||
| Acquired In Process Research And Development | $0.00 | $425.1M | $0.00 | |||
| Cost Of Goods And Services Sold | $7.1M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$55.8M | -$59.0M | -$53.2M | -$41.2M | -$462.5M | -$14.8M | -$19.6M | -$20.6M | -$21.7M | -$27.2M | -$34.9M | -$21.3M | -$22.0M | -$19.3M | -$20.4M | -$11.0M | -$8.6M | -$8.7M |
| Operating Income Loss | -$56.4M | -$63.6M | -$59.0M | -$48.1M | -$470.4M | -$20.2M | -$26.3M | -$26.1M | -$26.5M | -$29.3M | -$37.9M | -$28.2M | -$22.8M | -$20.4M | -$20.5M | -$11.5M | -$9.0M | -$9.2M |
| Other Comprehensive Income Loss Net Of Tax | $501.0K | -$225.0K | -$493.0K | $3.4M | -$245.0K | -$1.4M | $1.1M | -$1.5M | $2.6M | -$1.1M | -$761.0K | -$5.0M | -$369.0K | -$224.0K | -$576.0K | -$350.0K | $931.0K | $819.0K |
| Research And Development Expense | $28.8M | $27.4M | $24.6M | $27.7M | $29.2M | $12.8M | $18.6M | $18.6M | $18.8M | $21.3M | $28.9M | $20.7M | $17.1M | $14.0M | $15.9M | $8.6M | $7.3M | $7.3M |
| Nonoperating Income Expense | $642.0K | $4.6M | $5.8M | $6.9M | $7.9M | $5.4M | $6.7M | $5.5M | $4.8M | $2.1M | $3.0M | $6.9M | $812.0K | $1.1M | $82.0K | $512.0K | $418.0K | $474.0K |
| Comprehensive Income Net Of Tax | -$55.6M | -$59.9M | -$53.3M | -$38.6M | -$462.6M | -$16.1M | -$18.6M | -$22.1M | -$19.1M | -$28.3M | -$35.6M | -$26.3M | -$22.3M | -$19.6M | -$21.0M | -$11.4M | -$7.7M | -$7.9M |
| Operating Expenses | $66.2M | $65.8M | $60.0M | $47.3M | $470.5M | $20.2M | $26.3M | $26.1M | $26.5M | $29.3M | $37.9M | $28.2M | $22.8M | $20.4M | $20.5M | $11.5M | $9.0M | $9.2M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$55.8M | -$59.0M | -$53.2M | -$41.2M | -$462.5M | -$14.8M | -$19.6M | -$20.6M | -$21.7M | -$27.2M | -$34.9M | -$21.3M | -$22.0M | -$19.3M | -$20.4M | -$11.0M | -$8.6M | -$8.7M |
| General And Administrative Expense | $7.4M | $7.8M | $7.5M | $7.7M | $8.0M | $8.9M | $7.5M | $5.7M | $6.4M | $4.6M | $2.9M | $1.7M | $1.9M | |||||
| Selling General And Administrative Expense | $37.4M | $38.5M | $35.4M | $19.6M | $16.2M | $7.4M | $7.8M | $7.5M | ||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $13.1M | $4.8M | $3.1M | $727.0K | $1.4M | $0.00 | $0.00 | $0.00 | ||||||||||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $0.00 | -$1.0K | $3.0K | -$11.0K | -$7.0K | $1.0K | $12.0K | -$99.0K | ||||||||||
| Gross Profit | $9.8M | $2.3M | $990.0K | -$788.0K | $88.0K | $0.00 | $0.00 | $0.00 | ||||||||||
| Acquired In Process Research And Development | $0.00 | $0.00 | $0.00 | $425.1M | $0.00 | $0.00 | ||||||||||||
| Cost Of Goods And Services Sold | $3.3M | $2.6M | $2.1M | $1.5M | $1.3M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $305.7M | $463.8M | $605.1M | $655.1M | $746.0M | $215.1M | $117.7M |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$187.0K | $573.0K | $181.0K | -$5.5M | -$1.2M | $1.6M | $421.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $164.1M | $35.7M | $42.6M | $101.1M | $132.4M | $29.8M | $3.5M |
| Cash And Cash Equivalents At Carrying Value | $164.1M | $35.7M | $42.6M | $101.1M | $132.4M | $29.8M | |
| Retained Earnings Accumulated Deficit | -$1.12B | -$910.7M | -$342.8M | -$267.0M | -$162.8M | -$76.0M | |
| Liabilities And Stockholders Equity | $594.8M | $540.6M | $621.5M | $672.1M | $776.2M | $221.8M | |
| Assets | $594.8M | $540.6M | $621.5M | $672.1M | $776.2M | $221.8M | |
| Liabilities | $289.1M | $76.8M | $16.4M | $17.1M | $30.2M | $6.7M | |
| Assets Current | $571.5M | $526.3M | $616.4M | $667.3M | $772.1M | $220.7M | |
| Common Stock Value | $1.42B | $1.37B | $947.7M | $927.6M | $910.0M | $289.5M | |
| Debt Securities Unrealized Gain Loss | $741.0K | -$145.0K | $5.7M | -$4.3M | -$2.7M | ||
| Accrued Liabilities Current | $45.2M | $32.8M | $9.8M | $9.8M | $12.1M | $4.4M | |
| Liabilities Current | $82.2M | $58.2M | $14.0M | $13.2M | $16.9M | $6.6M | |
| Accounts Payable Current | $9.5M | $6.3M | $2.2M | $2.1M | $3.9M | $2.2M | |
| Property Plant And Equipment Net | $564.0K | $586.0K | $717.0K | $894.0K | $786.0K | $688.0K | |
| Warrant Liability | $0.00 | $2.1M | $353.0K | $850.0K | $11.0M | ||
| Marketable Securities Current | $365.1M | $467.0M | $568.6M | $559.9M | $633.0M | $186.0M | |
| Interest Receivable On Marketable Securities Current | $3.3M | $3.6M | $3.7M | $2.5M | $3.0M | $1.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $128.4M | -$6.9M | -$58.5M | -$31.3M | $102.7M | $26.3M | |
| Marketable Securities Realized Gain Loss | -$139.0K | -$1.2M | -$80.0K | $218.0K | |||
| Operating Lease Right Of Use Asset | $3.9M | $2.4M | $3.6M | $3.8M | $2.9M | $3.9M | |
| Operating Lease Liability Noncurrent | $2.5M | $969.0K | $2.0M | $3.1M | $2.2M | $3.1M | |
| Operating Lease Liability Current | $1.9M | $1.7M | $2.0M | $1.2M | $863.0K | $1.0M | |
| Prepaid Expense And Other Assets Current | $11.5M | $7.3M | $1.5M | $3.8M | $3.6M | $914.0K | |
| Non Cash Lease Expense | $275.0K | -$172.0K | -$67.0K | $285.0K | $184.0K | ||
| Lease Security Deposit Noncurrent | $145.0K | $141.0K | $138.0K | $421.0K | $421.0K | ||
| Gain Loss On Sale Of Property Plant Equipment | -$33.0K | $0.00 | -$10.0K | -$50.0K | $0.00 | ||
| Amortization Of Premium On Marketable Securities | $9.0M | $12.1M | -$3.7M | -$4.6M | |||
| Issuance Of Common Stock For Purchase Under Espp Value | $1.3M | $427.0K | $253.0K | -$388.0K | -$308.0K | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $620.0K | $1.2M | $2.2M | $3.9M | |||
| Other Assets Noncurrent | $7.6M | $6.8M | $587.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $325.9M | $372.9M | $419.5M | $502.7M | $257.2M | $594.0M | $611.6M | $624.6M | $641.1M | $667.9M | $693.1M | $723.6M | $769.4M | $788.9M | $806.3M | $91.8M | $102.9M | $110.2M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$139.0K | -$327.0K | $545.0K | $1.4M | -$1.3M | -$1.2M | -$3.3M | -$4.4M | -$2.9M | -$8.1M | -$7.0M | -$6.2M | $388.0K | $757.0K | $981.0K | $1.8M | $2.2M | $1.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $98.9M | $248.0M | $48.0M | $30.0M | $34.3M | $34.5M | $24.4M | $50.1M | $30.1M | $138.7M | $102.3M | $106.2M | $344.6M | $449.5M | $638.9M | $8.3M | $9.3M | $5.4M | |
| Cash And Cash Equivalents At Carrying Value | $98.9M | $248.0M | $48.0M | $30.0M | $34.3M | $34.5M | $24.4M | $50.1M | $30.1M | $138.7M | $102.3M | $106.2M | $344.6M | $449.5M | $638.9M | $1.3M | $3.4K | ||
| Retained Earnings Accumulated Deficit | -$1.08B | -$1.02B | -$964.0M | -$861.3M | -$820.1M | -$357.6M | -$329.0M | -$309.4M | -$288.7M | -$246.2M | -$219.0M | -$184.1M | $137.7M | $115.7M | $96.4M | -$735.3K | -$1.0K | ||
| Liabilities And Stockholders Equity | $601.6M | $647.2M | $492.5M | $571.6M | $594.8M | $613.1M | $630.9M | $641.4M | $657.1M | $686.5M | $719.7M | $751.8M | $797.8M | $814.3M | $832.1M | $145.5M | $171.1K | ||
| Assets | $601.6M | $647.2M | $492.5M | $571.6M | $594.8M | $613.1M | $630.9M | $641.4M | $657.1M | $686.5M | $719.7M | $751.8M | $797.8M | $814.3M | $832.1M | $145.5M | $171.1K | ||
| Liabilities | $275.7M | $274.3M | $73.0M | $68.9M | $62.7M | $19.1M | $19.3M | $16.8M | $16.0M | $18.6M | $26.7M | $28.2M | $28.4M | $25.3M | $25.7M | $974.0K | |||
| Assets Current | $577.5M | $623.2M | $475.6M | $565.0M | $587.2M | $608.1M | $625.3M | $637.2M | $652.6M | $681.4M | $714.3M | $748.0M | $796.6M | $813.1M | $830.9M | $1.7M | $3.4K | ||
| Common Stock Value | $1.40B | $1.40B | $1.38B | $1.36B | $1.08B | $952.8M | $943.9M | $938.4M | $932.7M | $922.2M | $919.0M | $913.9M | $906.6M | $903.9M | $901.7M | $91.00 | |||
| Debt Securities Unrealized Gain Loss | $501.0K | -$225.0K | -$493.0K | $3.4M | -$245.0K | -$1.4M | -$1.1M | -$1.5M | $2.6M | -$1.1M | -$761.0K | -$5.0M | -$369.0K | -$224.0K | -$576.0K | ||||
| Accrued Liabilities Current | $32.6M | $24.0M | $23.9M | $23.5M | $20.0M | $11.3M | $11.9M | $9.6M | $8.4M | $9.9M | $7.6M | $7.1M | $8.1M | $5.6M | $4.0M | $1.0K | |||
| Liabilities Current | $68.1M | $66.4M | $52.8M | $59.0M | $51.1M | $15.8M | $16.1M | $13.4M | $12.6M | $14.0M | $21.3M | $21.4M | $13.3M | $10.1M | $10.0M | $147.1K | |||
| Accounts Payable Current | $15.4M | $22.4M | $10.5M | $12.4M | $5.2M | $2.4M | $2.4M | $2.6M | $2.9M | $3.0M | $12.7M | $9.7M | $5.2M | $4.5M | $6.0M | ||||
| Property Plant And Equipment Net | $560.0K | $615.0K | $562.0K | $719.0K | $751.0K | $686.0K | $764.0K | $804.0K | $838.0K | $902.0K | $894.0K | $747.0K | $758.0K | $766.0K | $772.0K | ||||
| Warrant Liability | $1.7M | $2.4M | $2.8M | $908.0K | $1.4M | $1.8M | $590.0K | $972.0K | $708.0K | $1.2M | $1.6M | $4.7M | $14.9M | $15.1M | $15.6M | $0.00 | |||
| Marketable Securities Current | $450.1M | $359.8M | $413.7M | $519.1M | $542.9M | $562.5M | $594.9M | $580.8M | $616.5M | $535.3M | $601.5M | $631.5M | $447.2M | $357.1M | $185.8M | ||||
| Interest Receivable On Marketable Securities Current | $5.5M | $4.0M | $5.1M | $4.1M | $3.9M | $4.3M | $3.0M | $2.8M | $2.3M | $2.4M | $2.7M | $2.5M | $1.8M | $2.0M | $1.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $12.3M | -$8.1M | -$71.0M | -$26.2M | $609.1M | $1.9M | |||||||||||||
| Marketable Securities Realized Gain Loss | -$1.0K | $12.0K | -$99.0K | $96.0K | -$191.0K | -$694.0K | -$214.0K | $10.0K | $1.0K | $45.0K | -$119.0K | $48.0K | -$15.0K | ||||||
| Operating Lease Right Of Use Asset | $4.3M | $4.6M | $5.3M | $2.5M | $2.7M | $3.2M | $4.0M | $3.2M | $3.5M | $4.1M | $4.4M | $2.6M | |||||||
| Operating Lease Liability Noncurrent | $3.0M | $3.4M | $3.8M | $985.0K | $972.0K | $1.5M | $2.5M | $2.4M | $2.7M | $3.4M | $3.8M | $2.1M | |||||||
| Operating Lease Liability Current | $1.9M | $1.8M | $1.9M | $1.8M | $2.1M | $2.0M | $1.9M | $1.3M | $1.2M | $1.1M | $941.0K | $697.0K | |||||||
| Prepaid Expense And Other Assets Current | $8.9M | $8.3M | $8.4M | $11.6M | $6.0M | $6.8M | $3.0M | $3.5M | $3.7M | $3.0M | $4.5M | ||||||||
| Non Cash Lease Expense | $164.0K | -$38.0K | -$17.0K | $1.0K | $10.0K | ||||||||||||||
| Lease Security Deposit Noncurrent | $144.0K | $143.0K | $141.0K | $138.0K | $138.0K | $138.0K | $138.0K | $138.0K | $421.0K | $421.0K | $421.0K | $421.0K | |||||||
| Gain Loss On Sale Of Property Plant Equipment | $4.0K | -$34.0K | $0.00 | $0.00 | $0.00 | -$12.0K | $0.00 | ||||||||||||
| Amortization Of Premium On Marketable Securities | -$628.0K | -$174.0K | |||||||||||||||||
| Issuance Of Common Stock For Purchase Under Espp Value | $533.0K | $108.0K | $133.0K | $292.0K | |||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $3.7M | $0.00 | $3.9M | ||||||||||||||||
| Other Assets Noncurrent | $7.5M | $6.6M | $6.6M | $480.0K | $1.1M | $1.1M | $587.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$173.4M | -$130.4M | -$68.0M | -$96.1M | -$68.2M | -$36.5M |
| Net Cash Provided By Used In Investing Activities | $99.5M | $122.7M | $8.9M | $63.5M | -$454.7M | -$70.3M |
| Net Cash Provided By Used In Financing Activities | $202.5M | $331.0K | $628.0K | $1.3M | $625.5M | $133.1M |
| Increase Decrease In Accrued Liabilities | $12.4M | $6.8M | -$23.0K | -$2.3M | $7.5M | $2.9M |
| Share Based Compensation | $35.9M | $32.3M | $19.5M | $16.3M | $9.3M | $2.2M |
| Increase Decrease In Prepaid Expense | $4.3M | $3.0M | -$2.3M | $177.0K | -$2.4M | |
| Increase Decrease In Accounts Payable | $3.1M | -$1.7M | $70.0K | -$1.8M | $1.9M | $34.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $462.3M | $450.1M | $712.3M | $584.1M | $154.9M | $70.6M |
| Payments To Acquire Marketable Securities | $354.4M | $339.6M | $703.4M | $520.3M | $609.3M | $143.3M |
| Payments To Acquire Machinery And Equipment | $354.0K | $162.0K | $69.0K | $370.0K | $282.0K | $145.0K |
| Increase Decrease In Interest And Dividends Receivable | -$285.0K | -$132.0K | $1.2M | -$554.0K | $1.9M | $264.0K |
| Proceeds From Stock Options Exercised | $10.1M | $4.5M | $375.0K | $939.0K | $450.0K | |
| Increase Decrease In Other Noncurrent Assets | $846.0K | $6.0M | $587.0K | $0.00 | ||
| Payments Of Financing Costs | $11.9M | $17.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$42.6M | -$15.7M | -$19.3M | -$24.9M | -$14.7M | $8.7M | |
| Net Cash Provided By Used In Investing Activities | $54.2M | $7.5M | -$52.0M | -$5.6M | -$1.1M | $10.6M | |
| Net Cash Provided By Used In Financing Activities | $548.0K | $21.0K | $298.0K | $4.3M | $625.0M | $3.4K | |
| Increase Decrease In Accrued Liabilities | -$8.9M | $1.5M | -$1.5M | -$5.0M | -$701.0K | $1.0K | $87.0K |
| Share Based Compensation | $7.9M | $5.0M | $4.8M | $3.6M | $1.6M | $340.0K | |
| Increase Decrease In Prepaid Expense | $1.1M | $5.3M | -$137.0K | $4.2M | $3.9M | $1.2M | |
| Increase Decrease In Accounts Payable | $4.2M | $227.0K | $806.0K | $5.7M | $3.9M | $240.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $115.0M | $136.0M | $185.0M | $126.1M | $23.5M | $12.3M | |
| Payments To Acquire Marketable Securities | $60.7M | $128.4M | $237.0M | $131.7M | $24.5M | $1.5M | |
| Payments To Acquire Machinery And Equipment | $72.0K | $27.0K | $12.0K | $7.0K | $114.0K | $97.0K | |
| Increase Decrease In Interest And Dividends Receivable | $1.5M | $581.0K | -$212.0K | -$546.0K | -$77.0K | -$290.0K | |
| Proceeds From Stock Options Exercised | $1.1M | $21.0K | $298.0K | $314.0K | |||
| Increase Decrease In Other Noncurrent Assets | -$145.0K | $488.0K | $0.00 | ||||
| Payments Of Financing Costs | $534.0K | $0.00 | $76.6K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.60 | -$2.11 | -$0.35 | -$0.48 | -$0.44 | -$0.43 |
| Weighted Average Number Of Shares Outstanding Basic | 341.5K | 268.8K | 218.9K | 216.7K | 197.9K | |
| Weighted Average Number Of Diluted Shares Outstanding | 341.5K | 268.8K | 218.9K | 216.7K | 197.9K | |
| Earnings Per Share Basic | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 | |
| Common Stock Shares Outstanding | 337.8M | 337.8M | 219.0M | 218.6M | 217.9M | 149.0M |
| Common Stock Shares Issued | 337.8M | 337.8M | 219.0M | 218.6M | 217.9M | 149.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 197.9M | 97.5M | ||||
| Common Stock Shares Authorized | 1.06B | 346.5M | 1.17B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.17 | -$0.16 | -$0.15 | -$1.89 | -$0.07 | -$0.09 | -$0.09 | -$0.10 | -$0.12 | -$0.16 | -$0.10 | -$0.11 | -$0.09 | -$0.12 | -$0.12 | -$0.10 | -$0.10 | |||
| Weighted Average Number Of Shares Outstanding Basic | 342.4K | 340.7K | 338.6K | 273.6K | 244.7K | 219.0K | 218.9K | 218.8K | 218.7K | 218.3K | 216.6K | 213.4K | 207.1K | 204.0K | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 342.4K | 340.7K | 338.6K | 273.6K | 244.7K | 219.0K | 218.9K | 218.8K | 218.7K | 218.3K | 216.6K | 213.4K | 207.1K | 204.0K | |||||||
| Earnings Per Share Basic | $-0.16 | $-0.17 | $-0.16 | $-0.15 | $-1.89 | $-0.07 | $-0.09 | $-0.09 | $-0.10 | $-0.12 | $-0.16 | $-0.10 | $-0.11 | $-0.09 | |||||||
| Common Stock Shares Outstanding | 337.8M | 337.8M | 337.8M | 336.2M | 248.6M | 219.1M | 218.9M | 218.9M | 218.8M | 218.4M | 218.2M | 218.1M | 217.8M | 217.8M | 217.7M | ||||||
| Common Stock Shares Issued | 342.8M | 342.2M | 339.8M | 336.2M | 248.6M | 219.1M | 218.9M | 218.9M | 218.8M | 218.4M | 218.2M | 218.1M | 217.8M | 217.8M | 217.7M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 213.4K | 207.1K | 204.0K | 169.7K | 91.8K | 88.7K | 85.7M | ||||||||||||||
| Common Stock Shares Authorized | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B | 1.06B |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $35.9M | $32.3M | $19.5M | $16.3M | $9.3M | $2.2M |
| Fair Value Adjustment Of Warrants | $812.0K | $936.0K | -$497.0K | -$10.2M | -$4.2M | $0.00 |
| Professional Fees | $722.0K | $976.0K | $949.0K | $872.0K | $644.0K | $271.0K |
| Interest Income Other | $21.4M | $27.1M | $24.6M | $7.4M | $3.0M | $1.9M |
| Stock Issued During Period Value Stock Options Exercised | $10.1M | $4.5M | $375.0K | $939.0K | $450.0K | |
| Depreciation And Amortization | $1.7M | $683.0K | $222.0K | $199.0K | $184.0K | $103.0K |
| Stock Issued During Period Value New Issues | $0.00 | -$3.8M | $135.7M | |||
| Currency Translation Adjustment Value | -$1.5M | $537.0K | $0.00 | |||
| Translation Adjustment Functional To Reporting Currency Tax Expense Benefit | $1.5M | -$537.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.0M | $12.0M | $7.9M | $7.5M | $9.6M | $5.0M | $5.4M | $5.5M | $4.8M | $2.9M | $4.8M | $3.6M | $2.7M | $2.2M | $1.6M | $348.0K | $389.0K | $340.0K |
| Fair Value Adjustment Of Warrants | -$612.0K | -$454.0K | $751.0K | -$533.0K | -$1.1M | $1.5M | -$383.0K | $265.0K | -$142.0K | -$462.0K | -$3.1M | -$6.3M | -$125.0K | -$500.0K | $293.0K | $0.00 | $0.00 | |
| Professional Fees | $171.0K | $182.0K | $203.0K | $237.0K | $247.0K | $265.0K | $228.0K | $231.0K | $230.0K | $263.0K | $215.0K | $169.0K | $170.0K | $176.0K | $108.0K | $52.0K | $56.0K | $60.0K |
| Interest Income Other | $6.0M | $4.8M | $5.3M | $6.7M | $7.1M | $7.1M | $6.5M | $6.1M | $5.0M | $2.1M | $841.0K | $958.0K | $847.0K | $776.0K | $438.0K | $445.0K | $522.0K | $519.0K |
| Stock Issued During Period Value Stock Options Exercised | $558.0K | $762.0K | $1.1M | $1.7M | $1.9M | $21.0K | $77.0K | $298.0K | $258.0K | $56.0K | $314.0K | $30.0K | $190.0K | |||||
| Depreciation And Amortization | $310.0K | $58.0K | $56.0K | $46.0K | $30.0K | $24.0K | ||||||||||||
| Stock Issued During Period Value New Issues | -$3.8M | $25.0K | ||||||||||||||||
| Currency Translation Adjustment Value | -$313.0K | -$647.0K | $465.0K | -$742.0K | $148.0K | $0.00 | ||||||||||||
| Translation Adjustment Functional To Reporting Currency Tax Expense Benefit | $313.0K | $646.0K | -$465.0K | $742.0K | -$148.0K | $0.00 | $0.00 | $0.00 |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.